Kiwa Bio-Tech Products Group Corporation (KWBT)
Chart Events
Performance Outlook
| Previous Close | 0.0105 |
| Open | 0.0105 |
| Bid | 0.0025 x 5000 |
| Ask | 0.0041 x 5000 |
| Day's Range | 0.0090 - 0.0105 |
| 52 Week Range | 0.0030 - 0.0900 |
| Volume | 1,904,211 |
| Avg. Volume | 4,488,542 |
| Market Cap | 2.541M |
| Beta (5Y Monthly) | 1.47 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.2910 |
| Earnings Date | Nov 15, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- GlobeNewswire
Global Holding Group Will Participate In The Restructuring Of Kiwa Bio-Tech
Yangling, Shaanxi, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (PINK: KWBT) (“Kiwa Bio-Tech” or ‘the Company”), an emerging agricultural company that develops, manufactures and sells bio-fertilizers is pleased to announce that the Global Holding Group will participate in the restructuring of Kiwa Bio-Tech. Recently, the company and its strategic partner Shaanxi Xibaokun Agricultural Technology Co., Ltd., (“Xibaokun”), and the Global Holding Group have jointly established an industrial fund to promote the development of the new fertilizer industry in China based on the foundation of Kiwa Bio-Tech’s twenty-year biotechnology. They also participated in the Company’s restructuring process and a cooperation agreement was signed after several months’ discussions.The new fertilizer industry has taken a leading position in the field of agriculture and environmental protection, such as food safety control, soil remediation and treatment, improvement of crop quality, and protection of consumer health. Mr. Shizun Cai, the independent director and co-chairman of Global Holding Group stated that “the corporation is aimed to promote the integration of the new fertilizer industry and environmental protection industry by using the planned industrial funds as well as Kiwa’s state-of-the-art biotechnology. This cooperation will play a huge role in promoting the development of both industries, which have trillion RMB market. The goal of this cooperation is to make full use of the superior resources of all parties and establish a new standard and rule for the operation of this new fertilizer industry.”Under the terms of the agreement, the planned industrial fund will be used in the Company’s China operation restructuring. The Global Holding Group will hold 49 percent of the restructured Company. Kiwa will immediately resume the financial reports reporting after the restructuring. Along with this restructuring, Kiwa’s sales will be gradually entered into the Global Holding Group's network in China and the previous cooperation between Kiwa and Rong’s Family Group will also be initiated.Forward-Looking Statements This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.For investor and media inquiries, please contact: Gabby Yuan Email: gabby@kiwabiotech.com
- GlobeNewswire
Kiwa Bio-Tech Participated In The 22nd National Fertilizer Fair
Yangling, Shaanxi, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (OTCQB: KWBT) (“Kiwa Bio-Tech” or ‘the Company”), an emerging agricultural company that develops, manufactures and sells bio-fertilizers is pleased to announce that the Company showcased its bio-technological products at the 22nd National Fertilizer Fair. On November 5 to November 6, the 22nd National Fertilizer Fair, hosted by the National Agricultural Technology Extension Service Center of the Ministry of Agriculture and Rural Affairs, was held in Yangling, Shaanxi. This industry event has been rated as a National 4A agricultural professional exhibition for many years. The Company showcased its bio-technological products in this industry event, which aimed at strengthening production and demand docking, and promoting transformation and development.In this exhibition, more than 400 guests from all over the country including fruit farmers, vegetable farmers, tea farmers, and distributors, stayed in front of the company's exhibition showcase and asked about the company's products in detail. All the guests expressed their admiration and interests for the Company's 20 years of biotechnology research and development, as well as the five series of cutting-edge bio-fertilizer products developed by the Company. This exhibition focused on displaying the various products of the new fertilizer developed by the industry enterprises. Kiwa Bio-Tech’s KMF core microbial technology will give impetus to the development of China's new fertilizer industry.Forward-Looking StatementsThis press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.For investor and media inquiries, please contact: Gabby YuanEmail: gabby@kiwabiotech.com
- GlobeNewswire
KIWA BIO-TECH PRODUCTS GROUP CORP. August 2020 UPDATE
Yangling, Shaanxi, China, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corp. (KWBT) (“Kiwa Bio-Tech” or “the Company”), is pleased to provide this corporate update for all shareholders. To Kiwa’s Shareholders:Since the beginning of calendar year 2020, Kiwa has completed 60% of its planned sales during the first half year under the impact of the COVID-19 pandemic.Notwithstanding, since all of the sales revenue generated in this period were collected in Commercial Bank Notes, the Company faced a severe shortage of cash due to China's foreign exchange adjustments and note discount policy. On July 22, 2020, the Company executed a loan agreement with Shaanxi Agricultural Credit Financing Guarantee Company, however, at this date we have not received any funding from this line of credit.In response to this situation, the Board of Directors of the Company has urgently initiated a restructuring of its China business and management structure. The Company has been engaged in discussions and negotiations with various banks and Chinese investors for nearly two months. While there are no guarantees as to the success of these efforts, the Company now believes that additional bank funding will be available to the Company prior to September 30, 2020 and that certain Chinese investors will fund the purchase of new shares of common stock in the mid-September time frame.In tandem with the restructuring of its Chinese operations, the Board will also oversee the restructuring of its’ US operations. The Company currently plans to release its first, second, and third quarter quarterly reports at the same time.Forward-Looking StatementsThis press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.For investor and media inquiries, please contact: Gabby Yuan Email: gabby@kiwabiotech.com
